The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
Official Title: Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer: a Multi-center, Randomized, and Open-label Trial
Study ID: NCT02355249
Brief Summary: This study is a multi-center, randomized, and open-label trial to compare the safety and feasibility of traditional three incisions and minimally invasive thoracol-laparoscopic esophagectomy for esophageal cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Cancer Hospital of Chinese Academy of Medical Science, Beijing, Beijing, China
China-japan friendship hospital, Beijing, Beijing, China
Peking University Cancer Hospital, Beijing, Beijing, China
Peking University Third Hospital, Beijing, Beijing, China
Beijing Chao-Yang Hospital, Beijing, Beijing, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Quanzhou First Hospital, Quanzhou, Fujian, China
The People's Hospital Of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Hunan Cancer Hospital, Changsha, Hunan, China
Nantong Tumor Hospital, Nantong, Jiangsu, China
Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China
The First Hospital of China Medical University, Shenyang, Liaoning, China
The Second People's Hospital of Sichuan, Chengdu, Sichuan, China
Name: Jie He, MD
Affiliation: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR